Dose Dense Chemotherapy for Front-line Ovarian Cancer Treatment: The Price is Right?
Deputy Director- University of Cincinnati Cancer Institute, University of Cincinnati Medical Center, Medical Sciences Bldg, Suite 2005H, ML0662, 231 Albert Sabin Way, Cincinnati, OH 45267-0662.; Division of Gynecologic Oncology,Department of Obstetrics and Gynecology, Ohio State UniversityCollege of Medicine, Columbus, OH, United States. Electronic address: thomas.herzog@uc.edu.
Thomas J
TJ
Herzog
Deputy Director- University of Cincinnati Cancer Institute, University of Cincinnati Medical Center, Medical Sciences Bldg, Suite 2005H, ML0662, 231 Albert Sabin Way, Cincinnati, OH 45267-0662.; Division of Gynecologic Oncology,Department of Obstetrics and Gynecology, Ohio State UniversityCollege of Medicine, Columbus, OH, United States. Electronic address: thomas.herzog@uc.edu.
David E
DE
Cohn
D003362:Cost-Benefit Analysis; D005185:Fallopian Tube Neoplasms; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms